drugset / Trial / NCT03855202
The Treatment of Bronchopulmonary Dysplasia by Instillation PS and Mononuclaer Cells in Preterms
RandomizedParallel-groupDouble-blindPrevention
Summary
Bronchopulmonary dysplasia mainly occurs in premature infants, which is the main cause of premature infant death.If children with BPD can survive, they are also prone to complications of long-term respiratory diseases such as asthma,that affect the quality of life of BPD children. However, there is no effective treatment method for BPD. So,the investigator would like to investigate the effect of Intratracheal PS and mononuclaer cells in pretems
Timeline
- Start
- 2019-02-24
- Primary completion
- 2019-08-01
- Completion
- 2020-08-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CBMNC | Cell therapy | 25 cells/kg | Intrathecal |
| Subject | PS | Unknown | 70 mg/kg | Intrathecal |
Indications
No indication recorded.